BioCentury | May 8, 2019
Financial News
May 8 Financial Quick Takes: Trevi IPO, BMS, GeneQuantum
...close next quarter (see “Bristol-Myers’ Next Phoenix Act?” ). Chinese ADC play GeneQuantum raises $15M GeneQuantum Healthcare (Suzhou) Co. Ltd....
...which the company said uses an enzyme-catalyzed intelligent continuous conjugation process. Brian Moy, Assistant Editor Bristol-Myers Squibb Co. GeneQuantum Healthcare (Suzhou) Co. Ltd. Trevi...
...which the company said uses an enzyme-catalyzed intelligent continuous conjugation process. Brian Moy, Assistant Editor Bristol-Myers Squibb Co. GeneQuantum Healthcare (Suzhou) Co. Ltd. Trevi...
